We report RNA-Sequencing results on a cohort of patients with single suture craniosynostosis and demonstrate significant enrichment of heterozygous, rare, and damaging variants among key craniosynostosis-related genes. Genetic burden analysis identified a significant increase in damaging variants in ATR, EFNA4, ERF, MEGF8, SCARF2, and TGFBR2. Of 391 participants, 15% were found to have damaging and potentially causal variants in 29 genes. We observed transmission in 96% of the affected individuals, and thus penetrance, epigenetics, and oligogenic factors need to be considered when recommending genetic testing in patients with nonsyndromic craniosynostosis.
approximately 6-8% of patients have a positive family history that is consistent with autosomal dominant transmission (Boyadjiev, 2007; Lajeunie, Le Merrer, Bonaiti-Pellie, Marchac, & Renier, 1996) .
Examples of familial recurrence typically involve the same suture, although large pedigrees with coronal or sagittal synostosis have been described that exhibit significant intrafamilial variability (Boyadjiev, 2007; Cohen & MacLean, 2000) . This suggests that the pattern of suture fusion may not be a reliable method of clustering affected individuals. In addition, due to clinical overlap in the presentations of SSC and mild or atypical patients with Crouzon, Saethre-Chotzen, or Muenke syndromes (Boyadjiev, 2007) , phenotypically guided genetic testing may fail to identify rarer causes of disease (Miller et al., 2017) .
The use of next generation sequencing (NGS) and RNASequencing (RNA-Seq) technologies offer alternatives to phenotypically guided genetic testing methods. The benefits of RNA-Seq are twofold: gene variant detection can be conducted in ways analogous to exome sequencing, but with the added benefit of patient specific gene expression. Our use of calvarial osteoblasts cell lines from 391 SSC patients as an RNA source serves to enrich osteoblast candidate gene transcripts, and thus, variant detection, in ways that can be used to identify key pathway drivers in the development of SSC.
To date, most of the genetic testing for SSC has focused on sequencing hotspots of known craniosynostosis syndromes associated with coronal synostosis (FGFR1-3, TWIST1, EFNB1, TCF12), with low diagnostic yield (Heuze et al., 2014; Ye et al., 2016) . We sought to address these gaps by using RNA-Seq methodology and stringent filtering criteria to identify coding region variants in individuals diagnosed with SSC while providing patient specific expression data for future functional studies. In this study, we report rare, damaging alleles in 29 genes known to be associated with syndromic forms of craniosynostosis that are enriched in patients with SSC.
| MATERIALS AND METHODS

| Ethics statement
Written informed consent from all parents and guardians of children with SSC was obtained and a consent waiver was obtained for the use of anonymous control samples.
| Participant enrollment and cohort description
Three hundred and ninety-seven children were enrolled in the study at the time of treatment. Computed tomography scans confirmed the diagnosis of isolated SSC. Criteria for exclusion included the presence of major medical conditions or presence of three or more minor extracranial malformations. Calvaria and blood samples were obtained from the 397 individuals undergoing surgery and blood or saliva samples were collected from consented parents. Eighty-seven control samples were obtained from patients undergoing a craniotomy for reasons other than craniosynostosis (e.g., brain tumor, isolated hydrocephalus) or at the time of autopsy. All samples were screened for known pathogenic variants in FGFR1, FGFR2, FGFR3, TWIST1, EFNB1, and MSX2. Patients with these variants or chromosomal rearrangements were excluded from this analysis.
| Cell culture of primary osteoblasts
For participants with craniosynostosis, calvarial bone fragments were obtained from otherwise discarded tissues during surgical reconstruction. For control samples, calvarial bone was obtained from surgeries or autopsies. Bone fragments were used to establish osteoblast cell lines as described (Park et al., 2015) . 
| RNA isolation
| TruSeq stranded mRNA preparation
Next-generation sequencing libraries were prepared from 1.25 μg of total RNA in a high-throughput format using the TruSeq Stranded mRNA kit (Illumina, San Diego, CA). All the steps required for sequence library construction were automated and performed on a Sciclone
NGSx Workstation (Perkin Elmer, Waltham, MA). During library construction, rRNA was depleted by means of a poly-A enrichment and first and second strand cDNA syntheses were performed. Each library was uniquely barcoded using Illumina adapters and amplified by PCR.
After amplification and cleanup, library concentrations were quantified using the Quant-it dsDNA Assay (Life Technologies, Carlsbad, CA).
Final libraries were normalized and pooled based on Agilent 2100
Bioanalyzer results (Agilent Technologies, Santa Clara, CA) and size selected using a Pippin Prep (Sage Science, Beverly, MA). Pooled libraries were diluted to a final concentration of 2-3 nM for sequencing on a HiSeq 4000.
| Read processing and analysis pipeline
Samples were multiplexed and sequenced on a HiSeq 4000. Lane-level sequencing reads were base quality checked using the FASTX-toolkit and FastQC and aligned to hg19 with a reference transcriptome Ensembl v67 using TopHat2 suite (Kim et al., 2013) featureCounts (Liao, Smyth, & Shi, 2014 (Piskol, Ramaswami, & Li, 2013) . Reads with a mapping quality score less than 20 on a Phred scale (Li, Ruan, & Durbin, 2008) (Ramaswami & Li, 2014) .
All variants were annotated with ANNOVAR (Wang, Li, & Hakonarson, 2010 ) using refGene as a gene model. Variants were filtered for quality (coverage ≥5, Q ≥ 30), frequency in the Exome Aggregation Consortium ≤ 0.01 (ExAC) (Lek et al., 2016) , and in an exon, but not predicted to be synonymous. Next, variants were filtered by CADD (Kircher et al., 2014 ) (CADD_phred), GERP (Davydov et al., 2010 ) (GERP_RS + +) and Polyphen2 (Adzhubei et al., 2010 ) (Polyphen2_HDIV) scores. If variants passed all criteria (CADD ≥15, GERP ≥3 and Polyphen2 ≥0.9), they were considered potentially damaging alleles.
| Variant identification in genes associated with craniosynostosis
Variants meeting the above criteria were filtered against a list of 61 genes (Heuze et al., 2014; Twigg & Wilkie, 2015; Ye et al., 2016), 20 of which are associated with classic syndromic forms of craniosynostosis in >50% of individuals) and 41 genes associated with a syndrome in which craniosynostosis is seen as an occasional feature (<50%).
Minor Allele Frequency (MAF) scores for variants were obtained from the UCSC Genome Browser's dbSNP build 147 database (Kent et al., 2002; Speir et al., 2016) , ExAC (Lek et al., 2016) Table S2 ) using Primer3 software (Untergasser et al., 2012) and reference sequences from UCSC's Genome Browser (Kent et al., 2002; Speir et al., 2016) , (GRCh37/hg19). Variant sequences were aligned to the above reference sequences using Sequencher® version 5.1 DNA (Gene Codes Corporation, Ann Arbor, MI). In addition, alignments and chromatograms were visually inspected to confirm the variants of interest. Any variants that did not confirm the RNA-Seq results (4%) were removed from further analysis.
| DAVID functional annotation
To identify overlapping functional domains in the 29 genes with presumed damaging variants, the gene list was uploaded using the 
| Gene burden and variant enrichment analysis
Within each gene of interest we identified the number of rare exonic variants (ExAC MAF = ≤0.01) in both our proband and ExAC datasets that were predicted to be disruptive (nonsense, frameshift, or splice site) or missense variants with a CADD ≥15, GERP ≥3 and Polyphen2 ≥0.9. We analyzed these data for significant differences in the proportion of exonic variants in individual genes between our cohort and ExAC controls using a Fisher's exact test. Using the same parameters for identification of variants predicted to be disruptive or damaging we used a two-tailed Chi-square test with Yates correction to determine if damaging variants in all tested craniosynostosis genes were more common in our cohort than in the historical controls available in the ExAC database.
3 | RESULTS
| Cohort description
Three hundred and ninety-seven probands were enrolled in this study.
The prevalence of each suture type and male to female ratios (Table 1) is on par with previously described prevalence data (Di Rocco, Arnaud, & Renier, 2009; Kolar, 2011; Lajeunie, Le Merrer, Bonaiti-Pellie, Marchac, & Renier, 1995; Lajeunie et al., 1996; Lajeunie, Le Merrer, Marchac, & Renier, 1998; Selber et al., 2008; van der Meulen et al., 2009 Table S1 ).
Sixty-four of the 102 variants were significant and damaging, as defined by our stringent filtering parameters and statistical tests.
These 64 variants were found in 29 genes associated with syndromic craniosynostosis (Tables 3 and 4) . Following the classification methodology of Twigg and Wilkie (2015) , 15 variants were seen in eight genes considered to be core craniosynostosis genes ( Table S4 ). While this result could have been predicted based on our selection of known syndromic craniosynostosis genes, the aggregation of the variants we identified in these functional domains increases the likelihood of pathogenicity.
| Gene burden test
In addition to assessing variant level differences, we used genetic burden testing to determine if these patients had significant increases in the number of predicted damaging exonic variants when compared to ExAC controls. Using our filtering strategy we identified six genes (ATR, EFNA4, ERF, MEGF8, SCARF2, and TGFBR2) with a significantly increased number of predicted damaging variants between these patients and ExAC controls using the Fisher's exact test (Table 5) Table S1 ), are not statistically significant when compared to allele frequencies in UCSC; however, they may confer a predisposition to SSC occurrence (Merrill et al., 2006) . Twenty individuals in our cohort were identified with predicted damaging variants in one of these six genes with significantly increased variant burden representing approximately 5% of our sample. In order to select the genetic changes most likely to be pathogenic to the development of SSC, we restricted our analysis to nonsynonymous, damaging, exonic differences in genes already known to be associated with craniosynostosis. However, there are limitations to this approach, in that there may be splicing variants, nonsense mediated decay, null alleles, large duplications or deletions, and 5′ or 3′ regulatory elements, and novel genes that were excluded from this analysis. Also, the data for the eight genes with low RNA expression in primary osteoblasts were not included and thus, additional variants may reside in those genes as well.
Craniosynostosis is rarely the result of complete loss of gene function (Patel et al., 2014; Twigg et al., 2012; Twigg & Wilkie, 2015) .
Therefore, we propose that heterozygous missense changes in similar protein domains may perturb function to a degree that results in SSC, but without the other malformations associated with syndromic forms.
As such, we examined conserved protein structural domains using Analysis of this cohort of highly curated participants with SSC demonstrated heterozygous missense variants in genes, which when mutated, cause dominant, recessive, and X-linked forms of syndromic craniosynostosis. We demonstrated a significant enrichment of damaging variants in the expressed 53 craniosynostosis genes in our cohort relative to all expressed transcripts (p < 0.0001). Specific to our analyses, we identified 64 predicted damaging variants that were significantly more common in our cohort than the general population and represent 15% of the 391 patients. Although these data do not
prove causality, they demonstrate that predicted damaging variants in known syndromic craniosynostosis genes are more common in patients with isolated craniosynostosis. While each of the rare, consequences. This will require close collaborations between basic scientists, clinicians and genome scientists (Manolio et al., 2017) . To that end, future work on this cohort will include traditional differential gene expression analyses as well as correlation analysis of patient specific variants and expression data from osteoblast cell lines derived from affected individuals. These data will serve to guide additional research into the pathogenesis of single suture craniosynostosis. 
